CVD risk 'neutral' with early insulin

Doctors can be reassured that administering early insulin therapy to patients with risk factors for diabetes or diagnosed type 2 diabetes does not increase the risk of cancer or cardiovascular disease, according to new research.

The study of more than 12,000 people with cardiovascular risk factors and either pre-diabetes or type 2 diabetes found that using basal doses of insulin glargine to normalise fasting blood glucose levels had a neutral effect on CVD